These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29724584)
1. Stereotactic body radiation therapy for heart-base tumors in six dogs. Magestro LM; Gieger TL; Nolan MW J Vet Cardiol; 2018 Jun; 20(3):186-197. PubMed ID: 29724584 [TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases. Kruckman-Gatesy CR; Ames MK; Griffin LR; Boss MK; Rao S; Leary D; LaRue SM J Vet Cardiol; 2020 Feb; 27():62-77. PubMed ID: 32078943 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs. Hansen KS; Théon AP; Willcox JL; Stern JA; Kent MS Vet Comp Oncol; 2021 Mar; 19(1):191-200. PubMed ID: 33135852 [TBL] [Abstract][Full Text] [Related]
4. Use of three-dimensional conformal radiation therapy for treatment of a heart base chemodectoma in a dog. Rancilio NJ; Higuchi T; Gagnon J; McNiel EA J Am Vet Med Assoc; 2012 Aug; 241(4):472-6. PubMed ID: 22852573 [TBL] [Abstract][Full Text] [Related]
5. Single fraction stereotactic radiation therapy (stereotactic radiosurgery) is a feasible method for treating intracranial meningiomas in dogs. Kelsey KL; Gieger TL; Nolan MW Vet Radiol Ultrasound; 2018 Sep; 59(5):632-638. PubMed ID: 29873144 [TBL] [Abstract][Full Text] [Related]
6. Neuromuscular blockade and inspiratory breath hold during stereotactic body radiation therapy for treatment of heart base tumors in four dogs. Kelsey KL; Kubicek LN; Bacon NJ; Torres T; Robertson SA J Am Vet Med Assoc; 2017 Jan; 250(2):199-204. PubMed ID: 28058956 [TBL] [Abstract][Full Text] [Related]
7. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors. Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402 [TBL] [Abstract][Full Text] [Related]
8. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs. Hansen KS; Zwingenberger AL; Théon AP; Kent MS Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and adverse effects associated with stereotactic body radiation therapy in dogs with nasal tumors: 28 cases (2011-2016). Mayer MN; DeWalt JO; Sidhu N; Mauldin GN; Waldner CL J Am Vet Med Assoc; 2019 Mar; 254(5):602-612. PubMed ID: 30779620 [TBL] [Abstract][Full Text] [Related]
10. Canine primary liver tumors treated with stereotactic body radiation therapy: A case series. Chan QYP; Morrow D; Lurie D Vet Radiol Ultrasound; 2024 Mar; 65(2):121-129. PubMed ID: 38279767 [TBL] [Abstract][Full Text] [Related]
11. Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy. Zwingenberger AL; Pollard RE; Taylor SL; Chen RX; Nunley J; Kent MS J Vet Intern Med; 2016 May; 30(3):827-35. PubMed ID: 27149650 [TBL] [Abstract][Full Text] [Related]
12. Extra-adrenal retroperitoneal paraganglioma in a dog. Ilha MR; Styer EL J Vet Diagn Invest; 2013 Nov; 25(6):803-6. PubMed ID: 24105380 [TBL] [Abstract][Full Text] [Related]
13. Right atrial chromaffin paraganglioma in a dog. Wey AC; Moore FM J Vet Cardiol; 2012 Sep; 14(3):459-64. PubMed ID: 22840732 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Altwal J; Lee BI; Boss MK; LaRue SM; Martin TW Vet Comp Oncol; 2024 Mar; 22(1):125-135. PubMed ID: 38246695 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy. Trageser E; Martin T; Hoaglund E; Leary D; LaRue S; Boss MK Vet Comp Oncol; 2022 Jun; 20(2):491-501. PubMed ID: 34936172 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy. Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284 [TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338 [TBL] [Abstract][Full Text] [Related]
19. Clinical and imaging findings, treatments, and outcomes in 27 dogs with imaging diagnosed trigeminal nerve sheath tumors: A multi-center study. Swift KE; McGrath S; Nolan MW; Young M; Reese M; Rao S; Randall E; Leary D; LaRue S Vet Radiol Ultrasound; 2017 Nov; 58(6):679-689. PubMed ID: 28758278 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs. Gagnon J; Mayer MN; Belosowsky T; Mauldin GN; Waldner CL J Am Vet Med Assoc; 2020 Jan; 256(1):102-110. PubMed ID: 31841095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]